ISOTAMINE DIN 00261270
Health Canada record
| Active ingredient(s) | ISONIAZID 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J04AC01 ISONIAZID |
| Original market date | 31-Dec-1972 |
| Current status date | 07-Dec-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ISONIAZID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00577790 | PDP-ISONIAZID | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | ISONIAZID 100 MG | Marketed |
| 00577812 | PDP-ISONIAZID | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Solution | ISONIAZID 50 MG | Marketed |
| 00577804 | PDP-ISONIAZID | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | ISONIAZID 300 MG | Marketed |
| 02514923 | PMS-ISONIAZID | PHARMASCIENCE INC | Solution | ISONIAZID 50 MG | Approved |
| 02514907 | PMS-ISONIAZID | PHARMASCIENCE INC | Tablet | ISONIAZID 100 MG | Approved |
| 02514915 | PMS-ISONIAZID | PHARMASCIENCE INC | Tablet | ISONIAZID 300 MG | Approved |
| 02181428 | DOM-ISONIAZID 300MG TABLETS | DOMINION PHARMACAL | Tablet | ISONIAZID 300 MG | Cancelled Post Market |
| 00722464 | ISONIAZID SYRUP 50MG/5ML | CAROLINA MEDICAL PRODUCTS COMPANY | Syrup | ISONIAZID 50 MG | Cancelled Post Market |
| 00440108 | ISONIAZID TAB 100MG | SANDS PHARM | Tablet | ISONIAZID 100 MG | Cancelled Post Market |
| 00310247 | ISONIAZID TAB 300MG | SANDS PHARM | Tablet | ISONIAZID 300 MG | Cancelled Post Market |
| 00382779 | ISONIAZID TAB 50MG | SANDS PHARM | Tablet | ISONIAZID 50 MG | Cancelled Post Market |
| 02232756 | ISONIAZIDE 100MG TABLETS | LABORATOIRES CONFAB INC | Tablet | ISONIAZID 100 MG | Cancelled Pre Market |
| 00265500 | ISOTAMINE | BAUSCH HEALTH, CANADA INC. | Syrup | ISONIAZID 10 MG | Dormant |
| 00272655 | ISOTAMINE | BAUSCH HEALTH, CANADA INC. | Tablet | ISONIAZID 300 MG | Dormant |
| 00261289 | ISOTAMINE | BAUSCH HEALTH, CANADA INC. | Powder | ISONIAZID 500 G | Dormant |
| 00236799 | ISOTAMINE B 300 | BAUSCH HEALTH, CANADA INC. | Tablet | ISONIAZID 300 MG; PYRIDOXINE HYDROCHLORIDE 15 MG | Dormant |
| 00577782 | PDP-ISONIAZID | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | ISONIAZID 50 MG | Dormant |
| 02514893 | PMS-ISONIAZID | PHARMASCIENCE INC | Tablet | ISONIAZID 50 MG | Cancelled Pre Market |
International API supply for ISONIAZID
4 valid EDQM Certificates of Suitability from 4 holders. 4 active FDA Drug Master Files.
Request a quote for ISOTAMINE